Maravai Lifesciences Reports Second Quarter 2022 Financial R

04.08.2022 - Record First Half Revenue, EBITDA, Adjusted EBITDA and EPSSAN DIEGO, Aug. 04, 2022 (GLOBE NEWSWIRE) - Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech ...

Related Keywords

, Maravai Lifesciences , Deb Hart Maravai Lifesciences , Sara Michelmore Macdougall , Exchange Commission , Maravai Lifesciences Holdings Inc , Maravai Topco Holdings , Vector Laboratories Inc , Second Quarter , Months Ended June , Acid Production , Nucleic Acid Production , Safety Testing , Financial Guidance , Topco Holdings , Tax Receivable Agreement , Maravai Lifesciences Holdings , Accounting Standards Codification , Receivable Agreement , Net Income , Adjusted Net Income , Vector Laboratories , Maravai Topco , Earnings Per Share , Adjusted Diluted , Securities Litigation Reform Act , Annual Report , Quarterly Report , Contact Information , Media Contact , Sara Michelmore Macdougall Advisors ,